AMG 282
Sponsors
Amgen
Conditions
AsthmaChronic Rhinosinusitis With Nasal Polyps
Phase 1
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
CompletedNCT01928368
Start: 2013-08-31End: 2016-03-31Updated: 2016-12-14
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps
CompletedNCT02170337
Start: 2014-07-31End: 2016-05-31Updated: 2016-06-01